Wednesday, November 15, 2017
Print Current Session:
|
|
Wednesday
SESSION 38:
ISSUES WITH TRIALS; RCTs; GUIDELINES; STANDARDS; REGISTRIES; QUALITY INITIATIVES; THE SVS AND THE JVS
Location: Grand Ballroom West, 3rd Floor
Moderators:Anne L. Abbott, MD, PhD, FRACP / Joseph L. Mills, MD |
|
SESSION 38 SCHEDULE | |
4:36 PM - 4:41 PM | Interpreting RCTs Of AAA Or Carotid Treatments: Why And How They Can Be Misleading Or Misinterpreted |
Presenter(s):Thomas L. Forbes, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:42 PM - 4:47 PM | Propensity Matched Clinical Trials Have Value: But They Can Also Have Limitations And Flaws: How To Maximize Their Value |
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:48 PM - 4:53 PM | DEBATE: Status Of The BEST Trial – A RCT Of CLI Treatments (Endo vs. Open): Laudable But Difficult: It Will Provide Useful Information |
Presenter(s):Alik Farber, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:54 PM - 4:59 PM | DEBATE: The BASIL 2 And 3 Trials; RCTs Of (2) Vein Bypasses vs. Endovascular First Treatments For CLI; And (3) DCBs And DESs vs. PTA With BMS Bailout: They Will Provide Useful Information |
Presenter(s):Andrew W. Bradbury, MD, FRCSEd Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:00 PM - 5:05 PM | DEBATE: These Trials Will Be Fraught With Problems And May Provide Little Useful Information |
Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:06 PM - 5:11 PM | The WIFI Grading System For CLTI Is Meaningful: WIFI Scores Correlate Well With The Risks Of Amputation And Death Following Treatment |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:12 PM - 5:17 PM | How Can The WIFI Grading System Influence Patient Outcomes With CLTI |
Presenter(s):Robert S. Crawford, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:18 PM - 5:23 PM | Panel Discussion |
Moderator(s): Michael S. Conte, MD / Peter Gloviczki, MD | |
5:24 PM - 5:29 PM | What Is The SVS/VQI/FDA TEVAR For Aortic Dissection Registry: What New And Useful Information Will It Provide |
Presenter(s):Richard P. Cambria, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:30 PM - 5:35 PM | What Is The International Consortium Of Vascular Registries (ICVR): What Unique And Valuable Information Can Be Learned From It |
Presenter(s):Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:36 PM - 5:41 PM | New Reporting Standards For Lower Extremity Endovascular Treatments For Ischemia: How Will They Help Bring Order Out Of Chaos |
Presenter(s):Michael C. Stoner, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:42 PM - 5:47 PM | New Developments In The SVS VQI And How It Can Benefit Patients And Vascular Surgeons |
Presenter(s):Larry W. Kraiss, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:48 PM - 5:53 PM | Increasing Disparity Between SVS AAA Guidelines And Real World Practice For AAA Repair: The Guidelines Are No Longer Relevant: What Harm Can This Cause And What Is The Solution |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:54 PM - 5:59 PM | New Developments With The Journal Of Vascular Surgery And How They Can Be Beneficial |
Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
6:00 PM - 6:06 PM | Panel Discussion End of Program F |
END OF SESSION 38 | |
previous | next |